TITLE

CLINIC ROUNDUP

PUB. DATE
June 2008
SOURCE
BioWorld Today;6/3/2008, Vol. 19 Issue 107, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs on clinical trials of various drugs as of June 2008. AMAG Pharmaceuticals Inc. reported positive results from two Phase III studies of ferumoxytol as iron replacement therapeutic agent in patients with chronic kidney disease with functioning kidney transplants. Hemispherx Biopharma Inc. announced that it completed enrollment in a Phase II trial to evaluate Ampligen as an enhancer for seasonal influenza vaccine. Human Genome Sciences Inc. started dosing in a Phase I study of its lead IAP inhibitor, HGS1029.
ACCESSION #
32481747

 

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics